Casa di Cura IGEA: Clinical Trials

5 trials sponsored by Casa di Cura IGEA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting, 1 enrolling by invitation. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Enrolling by invitation 1, Recruiting 1

Follow Casa di Cura IGEA: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Exercises for Rehabilitation of COgnition and Lifestyle Enhancement in Patients With Mild Cognitive Impairment
Multimodal Group Cognitive Rehabilitation Intervention, Active Control - Mild Cognitive Impairment (MCI)
Not applicableRecruitingCasa di Cura IGEA402026-02-162026-04-08
Clinical Impact Through AI-assisted MS Care - A Prospective Multi-center Study
quantitative brain MRI (icobrain mr), Standard of Care (SOC) - Multiple Sclerosis, Radiologically Isolated Syndrome
Not applicableEnrolling by invitationicometrix7502025-10-092025-12-09
Validation of α-synuclein Modifications in Parkinson's dIsoRder Evolution
Blood draw for the laboratory assessment - Parkinson Disease (PD)
RecruitingCasa di Cura IGEA12002025-05-122026-03-02
Italian Adaptation and Validation of Functional and Behavioural Scales for Subjective Cognitive Decline, Mild Cognitive Impairment and Mild Dementia.
Neurologically Unimpaired Elderly Participants, Subjective Cognitive Decline (SCD)
RecruitingCasa di Cura IGEA3902024-11-262025-02-13
Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
Multiple Sclerosis, NMO Spectrum Disorder
Recruitingicometrix70002024-03-012025-12-12

Conditions studied

Cognitive Dysfunction (2)  ·  Multiple Sclerosis (2)  ·  Disease Progression (1)  ·  Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (1)  ·  Nerve Degeneration (1)  ·  Neuromyelitis Optica (1)  ·  Parkinson Disease (1)  ·  Parkinson Disease 4, Autosomal Dominant Lewy Body (1)

Interventions

Blood Specimen Collection (1)  ·  Standard of Care (1)

Countries

Italy (4)  ·  Czechia (2)  ·  Germany (2)  ·  Greece (1)  ·  Poland (1)  ·  Spain (1)

Top investigators

Sabrina Guzzetti (2)  ·  Elda Judica, MD (1)  ·  Friedemann Paul, PhD, MD (1)  ·  Marco Feligioni, PHD (1)

Results publications

PMID 11001602, PMID 11124735, PMID 1202204, PMID 14044222, PMID 15324367, PMID 18590364, PMID 21514249, PMID 21514250, PMID 21691143, PMID 24798886, PMID 34989910, PMID 5349366, PMID 7069156, PMID 8954307, PMID 9153155